v3.22.2.2
Loss Per Share (Details) - Schedule of common share equivalent basis and outstanding - shares
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total diluted shares 193,235,190 162,706,400
Convertible notes payable [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total diluted shares 193,235,190 162,706,400